Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04844840 · ClinicalTrials.gov registry record · Phase 2
A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence
A Phase 2 study, sponsored by Sirnaomics.
- Completed
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
NCT04844840: Completed Phase 2 study, sponsored by Sirnaomics.
NCT04844840 is a Phase 2 study that has completed, run by Sirnaomics. The registered enrollment target is 29 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04844840, a Phase 2 study, has completed, sponsored by Sirnaomics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
Study Summary
Phase 2, randomized, double-blind, multiple arm, controlled study to evaluate safety \& efficacy of various doses of STP705 in reducing post Keloidectomy keloid recurrence.
Primary Outcome
Rate of recurrence in subjects undergone surgery alone (with or without placebo) vs surgery and STP705
Interventions
- OTHER Placebo
- DRUG STP705
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2021-04-29 |
| Est. Completion | 2023-05-17 |
| Phase | Phase 2 |
What the finished NCT04844840 record still lists
NCT04844840 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04844840 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04844840 about?
NCT04844840 is a clinical study titled "A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence". Phase 2, randomized, double-blind, multiple arm, controlled study to evaluate safety \& efficacy of various doses of STP705 in reducing post Keloidectomy keloid recurrence.
What is the current status of trial NCT04844840?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2021-04-29. Estimated completion is 2023-05-17.
What interventions are being tested in trial NCT04844840?
The interventions under investigation include: Placebo (OTHER), STP705 (DRUG).
Who is sponsoring clinical trial NCT04844840?
This trial is sponsored by Sirnaomics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04844840's enrollment target sits among peer trials
29 1669th of 2000 higher than 324 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI